Listing ID : 886294
Broker ID : 17608817997
Listed On March 1, 2025 42
Listing Updated March 1, 2025
- Licence(s) Held: GMP-certified pharmaceutical manufacturing license, ANVISA Import Permits (Brazil), DEA Import Permits (United States), Licensed for controlled substance manufacturing and export
- Leading Jamaican pharmaceutical cannabis manufacturer, uniquely positioned to capitalize on the rapidly growing US and Brazilian markets by offering the highest level of quality, medical-grade products, and regulatory compliance that surpass traditional medical cannabis offering
- Company has an exclusive 5-year supply agreement in Brazil to provide pharmaceutical THC into a state-owned pharma network, serving over 40 million people with 100% insurance reimbursement.
- Positioned for direct-to-consumer and direct-to-pharmacy distribution in the US, aligning with the DEA’s expected rescheduling of THC to Schedule III in 2025.
- Over 100 pharmaceutical THC shipments have been successfully exported to Brazil and the US under DEA and ANVISA import permits.
- Established strategic joint venture in Brazil with a leading distributor grants access to 13,000 pharmacies and 300,000 food and beverage points of sale across all 27 Brazilian states.
- EBITDA is forecasted to be positive by Q4 2025, with projected revenues of $10.8M for 2025 and $36.5M by 2026, driven by long-term contracts.
- Proven leadership team, consisting of seasoned executives with expertise in pharmaceuticals, consumer goods, and cannabis, including early pioneers of leading cannabis firms.
- The GMP-certified facility allows for white-label manufacturing for US brands seeking compliant, pharmaceutical-grade THC for legal distribution across all 50 states post-rescheduling.
- Company has invested $10M USD to date, supported by a licensed and GMP-certified pharmaceutical manufacturing facility located in a Free Trade Zone.
- The 5-year DCF valuation stands at $138M, representing significant investment upside based on projected sales, market expansion, and regulatory tailwinds.
- Seeking US $10M in equity financing at a $20M pre-money valuation to accelerate global market expansion
- Company is headquartered in Canada
-
Cannabis & Hemp Banking
-
Buy or Sell a Business on BizTrader
FEATURED LISTINGS
RECENT LISTINGS
Listings You May Also Like
Canada
Licence(s) Held: GMP-certified pharmaceutical manufacturing license, ANVISA Import Permits (Brazil), DEA Import Permits (United States), Licensed for
Lake County, CA, USA
Hello,Im looking to do a gross profit split 80/20 for 1-2 acres of licensed outdoor canopy in lake county Ca. Depending on set up im willing to nego
Germany
Premier medical operator in Poland, focused on patient-centric online services, specializing in the provision of medical clinics and cannabis treatmen
Germany
First mover to bring standardized cannabinoid APIs based on phyto-complex to the Italian marketCompany is operational, pre-revenue, focused exclusivel